Literature DB >> 20576727

Specific requirements for bloodless cardiopulmonary bypass in neonates and infants; a review.

Hanna D Golab1, Johanna Jm Takkenberg, Ad J J C Bogers.   

Abstract

A miniaturized cardiopulmonary bypass circuit enables the safe performance, in selected pediatric patients, of bloodless open heart surgery. As the latest survival rates in neonatal and infant cardiac surgery have become satisfactory, investigators have concentrated upon the improvement of existing procedures. Institutional guidelines and multidisciplinary efforts undertaken in the pre- and postoperative periods are of great importance, concerning bloodless CPB and should be seriously pursued by all involved caregivers. This review reflects upon the selective, most relevant requirements for success of asanguinous neonatal and infant CPB: acceptable level of hemodilution during the CPB, patient preoperative hematocrit value and volume of CPB circuit. We present an assessment of practical measures that were also adapted in our institution to achieve an asanguinous CPB for neonatal and infant patients.

Entities:  

Mesh:

Year:  2010        PMID: 20576727     DOI: 10.1177/0267659110375862

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  3 in total

1.  The neonatal circuit: in search of the ultimate solution.

Authors:  Filip De Somer
Journal:  J Extra Corpor Technol       Date:  2012-03

2.  The influence of cardiopulmonary bypass priming without FFP on postoperative coagulation and recovery in pediatric patients with cyanotic congenital heart disease.

Authors:  Xiaolei Miao; Jinping Liu; Mingxia Zhao; Yongli Cui; Zhengyi Feng; Ju Zhao; Cun Long; Shoujun Li; Fuxia Yan; Xu Wang; Shengshou Hu
Journal:  Eur J Pediatr       Date:  2014-05-27       Impact factor: 3.183

3.  Superior blood-saving effect and postoperative recovery of comprehensive blood-saving strategy in infants undergoing open heart surgery under cardiopulmonary bypass.

Authors:  Ting Wu; Jianshi Liu; Qiang Wang; Peijun Li; Guoning Shi
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.